Search Results

Kite, a Gilead Company Named Presenting Sponsor of Celebration & Community for LLS’s National Light The Night Events

Rye Brook, NY, (October 24, 2022) – The Leukemia & Lymphoma Society (LLS) announced today that Kite, a Gilead Company has signed a two-year agreement …

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

[Rye Brook, NY], October 25, 2022 – Fast Company announced today its second annual Brands That Matter list, honoring brands that communicate and demon…

Awards

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma

The Food and Drug Administration (FDA) has approved a new treatment, teclistamab (Tecvayli), for adults with multiple myeloma that has returned or con…

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

no-float col-12 (RYE BROOK, N.Y., November 1, 2022) - The Leukemia…

Leslie Crews

Dr. Leslie Crews is an Assistant Professor of Medicine at UCSD with a passion for stem cell biology and translational cancer research. She received he…

Inflammation-responsive mechanisms of malignant stem cell generation and eradication in multiple myeloma

The focus of my research is to elucidate the core molecular regulators of malignant stem cell generation in multiple myeloma. My approach addresses th…

Robert Soiffer

Robert J. Soiffer, MD, is Chief of the Division of Hematologic Malignancies and Chair of the Executive Committee for Clinical Programs at Dana Farber …

Understanding and Overcoming Mechanisms of Immune Evasion after Allogeneic Transplant

Outcomes for patients with acute myelogenous leukemia who relapse after transplantation are dismal. This SCOR brings together an international group o…

Research Now: New Research on COVID & Blood Cancer

The transcript and FAQ below provide additional information for participants in the webinar LLS Research Now: NEW Research on COVID & Blood Cancer, he…

Alesia

In November 2021, I experienced my first panic attack while at work. I went to the urgent care clinic, and they tested me and said I was good and migh…

Amanda

I am now a two-time acute myeloid leukemia (AML) survivor. When I was diagnosed with AML, it was an absolute complete shock. At the time of my diagnos…

Brent

My nephew Brent Terence was a perfectly healthy 17-year-old young man, active in school, up-to-date on his routine check-ups, and had normal labs. But…

Grace

I went to a simple doctor's appointment on October 27, and from that day on, my life flipped upside down. I was diagnosed with acute lymphoblastic leu…

Heriberto

I was diagnosed with Burkitt lymphoma (BL) on Friday the 13th ― August 13, 2021, to be exact ― seven months after being married, three months after my…

Jim

Stay focused, stay positive, live as life as normally as you did before diagnosis, and do your best. I was diagnosed with chronic lymphocytic l…

Jonathan

I’ll start from the beginning.In 2012, I was diagnosed with testicular cancer. I had surgery to remove the mixed germ cell tumor and then was on the r…

Winter

In July 2021, I began to notice that I was not feeling like myself. I became tired very easily, and keeping up with my children was increasingly diffi…

Jonathan

I was diagnosed with diffused large B-cell lymphoma (DLBCL) with concentrations in the brain and lungs. Lymphoma itself is a cancer that starts in the…

Elisabeth

I was first diagnosed at 12 years old when I didn’t even know what the word cancer meant. I remember sitting at the kitchen table with my family, layi…

Tak Mak

Tak W. Mak is an international leader in cancer and immunology research. He is best known for his cloning of the human T cell receptor in 1984, which …

The Immune Niche in the Development of Hematological Malignancies and Implications for Novel Therapy

Our SCOR Program, composed of four complementary Projects supported by three shared Cores, is designed to determine how the immune niche and factors i…

Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases

The U.S. Food and Drug Administration (FDA) this week approved cobimetinib (Cotellic®), a precision medicine treatment for adults with any of a family…